US Stock MarketDetailed Quotes
BIOR Biora Therapeutics
- 3.3494
- -0.0806-2.35%
Close Nov 1 16:00 ET
- 3.4800
- +0.1306+3.90%
Post 20:02 ET
14.54MMarket Cap-68P/E (TTM)
3.4885High3.3100Low28.88KVolume3.4400Open3.4300Pre Close98.42KTurnover0.90%Turnover RatioLossP/E (Static)4.34MShares19.900052wk High-0.16P/B10.72MFloat Cap3.310052wk Low--Dividend TTM3.20MShs Float3980.0000Historical High--Div YieldTTM5.20%Amplitude3.3100Historical Low3.4080Avg Price1Lot Size
Biora Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 5.76%-10.95M | -3.29%-12.5M | 26.71%-48.5M | -26.52%-13.75M | -11.48%-11.03M | 42.25%-11.62M | 52.16%-12.1M | 52.84%-66.18M | 76.73%-10.86M | 76.16%-9.9M |
| Net income from continuing operations | 136.31%6.47M | 75.98%-4.19M | -225.27%-124.12M | -12.32%-15.41M | -1,336.33%-73.45M | -223.00%-17.81M | -26.31%-17.44M | 84.58%-38.16M | 85.22%-13.72M | 88.31%-5.11M |
| Operating gains losses | -14,284.47%-22.84M | -1,553.57%-14.14M | 307.48%48.49M | 120.20%548K | 2,737.36%48.63M | 101.60%161K | 90.21%-855K | -148.58%-23.37M | -104.49%-2.71M | -162.17%-1.84M |
| Depreciation and amortization | -33.73%110K | -28.57%105K | -38.81%555K | -25.95%117K | -38.12%125K | -26.22%166K | -54.35%147K | -36.88%907K | -57.64%158K | 104.04%202K |
| Other non cash items | -11.23%340K | 418.45%1.94M | 114.93%1.38M | -58.71%256K | 103.92%369K | 387.97%383K | 210.32%374K | -113.13%-9.25M | -94.07%620K | -382.85%-9.4M |
| Change In working capital | -1.85%3.4M | -29.60%2.25M | 285.31%8.62M | -130.41%-799K | -36.09%2.76M | 156.05%3.46M | 158.87%3.19M | 82.02%-4.65M | 109.54%2.63M | 149.25%4.32M |
| -Change in receivables | --0 | --8K | 99.76%-2K | ---12K | --0 | --10K | --0 | ---828K | --0 | ---11K |
| -Change in prepaid assets | -14.80%-954K | -5.70%728K | -70.53%998K | -86.43%264K | -66.18%793K | 71.96%-831K | -62.52%772K | 142.10%3.39M | -45.06%1.95M | -14.57%2.35M |
| -Change in payables and accrued expense | -3.53%4.57M | -40.03%1.72M | 273.16%9.51M | -181.07%-745K | 5.21%2.64M | 350.87%4.73M | 140.85%2.87M | 82.58%-5.49M | 103.12%919K | 123.35%2.51M |
| -Change in other current liabilities | 52.21%-216K | 53.32%-211K | -9.53%-1.88M | -28.57%-306K | -28.63%-674K | 10.85%-452K | -0.22%-452K | -138.98%-1.72M | 83.22%-238K | 31.14%-524K |
| Cash from discontinued investing activities | 0 | 0 | 106.47%1.76M | -102.32%-154K | 105.55%93K | |||||
| Operating cash flow | 5.76%-10.95M | -3.29%-12.5M | 24.71%-48.5M | -24.75%-13.75M | -12.53%-11.03M | 40.82%-11.62M | 49.50%-12.1M | 61.54%-64.42M | 72.49%-11.02M | 77.30%-9.81M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -847.37%-180K | 50,183.33%3.01M | 88.38%-92K | 8.33%-66K | 99.39%-1K | 91.12%-19K | 98.25%-6K | 7.37%-792K | -72K | -8,100.00%-164K |
| Net PPE purchase and sale | -847.37%-180K | 183.33%5K | 88.38%-92K | 8.33%-66K | 99.39%-1K | 91.12%-19K | 98.25%-6K | 7.37%-792K | ---72K | -8,100.00%-164K |
| Net business purchase and sale | ---- | --3M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -847.37%-180K | 50,183.33%3.01M | 408.46%2.44M | 3,529.17%2.47M | 99.39%-1K | 91.12%-19K | 98.25%-6K | 36.23%-792K | -134.12%-72K | 62.04%-164K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -26.12%5.64M | -57.78%5.1M | 321.77%30.78M | 208.19%13.92M | -92.82%-2.85M | 578.22%7.63M | 285.48%12.08M | -95.63%7.3M | -93.99%4.52M | -104.64%-1.48M |
| Net issuance payments of debt | --0 | --2.81M | 83,433.33%10M | --10M | --0 | --0 | --0 | 99.27%-12K | --0 | --0 |
| Net common stock issuance | --3.3M | -78.27%2.8M | 101.21%18.14M | 98.09%5.07M | -89.09%181K | --0 | 255.30%12.88M | -80.73%9.01M | -89.04%2.56M | 5,430.00%1.66M |
| Proceeds from stock option exercised by employees | ---- | ---- | 134.19%8M | --0 | --0 | ---- | ---- | -97.28%3.42M | -92.77%3.33M | --0 |
| Net other financing activities | -30.81%-484K | 36.03%-513K | -4.61%-5.36M | 15.82%-1.16M | 3.41%-3.03M | -180.30%-370K | -67.08%-802K | -36.53%-5.12M | -119.26%-1.37M | 61.49%-3.14M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -26.12%5.64M | -57.78%5.1M | 321.77%30.78M | 208.19%13.92M | -92.82%-2.85M | 578.22%7.63M | 285.48%12.08M | -95.58%7.3M | -93.86%4.52M | -104.65%-1.48M |
| Net cash flow | ||||||||||
| Beginning cash position | -64.48%10.82M | -50.10%15.21M | -65.51%30.49M | -66.08%12.57M | -45.47%26.45M | -54.69%30.46M | -65.51%30.49M | -4.00%88.4M | -31.54%37.06M | -26.50%48.51M |
| Current changes in cash | -37.00%-5.5M | -18,991.30%-4.39M | 73.62%-15.28M | 140.19%2.64M | -21.29%-13.88M | 78.58%-4.01M | 99.89%-23K | -1,474.10%-57.91M | -119.50%-6.57M | 3.45%-11.45M |
| End cash Position | -79.87%5.33M | -64.48%10.82M | -50.10%15.21M | -50.10%15.21M | -66.08%12.57M | -45.47%26.45M | -54.69%30.46M | -65.51%30.49M | -65.51%30.49M | -31.54%37.06M |
| Free cash flow | 4.38%-11.13M | -3.28%-12.51M | 25.47%-48.6M | -24.54%-13.81M | -10.69%-11.04M | 41.36%-11.64M | 50.14%-12.11M | 61.26%-65.21M | 72.31%-11.09M | 76.92%-9.97M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data